Advert Merck Serono
Homecare Service and conduct of a representative
-
Date posted01 February 2021
-
SanctionAdvertisement,
-
Case number/s
For promoting a homecare delivery service for Mavenclad (cladribine) but not interacting with those with direct responsibility for such services within the NHS, and for not being clear about the company’s relationship with the service provider, Merck Serono was ruled in breach of the following clauses of the Code:
Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry
Clause 9.1 - Failing to maintain high standards
Clause 9.10 - Failing to clearly indicate its sponsorship of material
Clause 15.2 - Representative failing to maintain a high standard of ethical conduct
Clause 15.4 - Representative failing to observe the arrangements in place at a particular establishment